TGM2 and cancer: The multi-functional nature of TG2 with its enzymatic, GTPase, or scaffold properties suggests that the specific inhibition of TG2 in CSCs depends on cell type context and further evaluation of TG2 inhibitors, either alone or in combination with standard chemotherapeutic agents, is warranted in distinct cancer models.